Back to top
more

West Pharmaceutical Services (WST)

(Delayed Data from NYSE)

$318.02 USD

318.02
984,748

+0.10 (0.03%)

Updated Jul 22, 2024 04:00 PM ET

After-Market: $318.06 +0.04 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (149 out of 250)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Here's Why You Should Invest in West Pharmaceutical (WST) Now

West Pharmaceutical (WST) continues to gain momentum on the back of strength in Proprietary Products business.

Riya Anand headshot

3 High-Potential MedTech Stocks With More Than 50% Growth YTD

Stocks like West Pharmaceuticals Services (WST), Maravai LifeSciences (MRVI) and Option Care Health (OPCH) have gained stupendously year to date.

Here's Why You Should Retain BD (BDX) Stock in Your Portfolio

Investors continue to be optimistic about BD (BDX) owing to its slew of product launches and regulatory approvals.

Masimo's (MASI) EMMA Capnography on Neonates Favored by New Study

Masimo's (MASI) EMMA is likely to aid in maintaining an optimal range of PaCO2 in preterm infants undergoing mechanical ventilation in the neonatal intensive care unit.

Why West Pharmaceutical (WST) Could Be an Impressive Growth Stock

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider West Pharmaceutical (WST).

The Zacks Analyst Blog Highlights: West Pharmaceutical Services, The Mosaic Co, AutoZone, O'Reilly Automotive and Ulta Beauty

The Zacks Analyst Blog Highlights: West Pharmaceutical Services, The Mosaic Co, AutoZone, O'Reilly Automotive and Ulta Beauty

Nalak Das headshot

S&P 500 Records a Broad-Based Rally YTD: 5 Top-Ranked Picks

We have narrowed down our search to five large-cap S&P 500 stocks that have strong growth potential for the rest of 2021. These are AZO, MOS, ULTA, ORLY, and WST.

Here's Why You Should Retain Masimo (MASI) Stock For Now

Investors continue to be optimistic about Masimo (MASI) owing to its slew of product launches and regulatory approvals.

Cutera, NetEase, West Pharmaceutical, IDEXX Laboratories and Align Tech highlighted as Zacks Bull and Bear of the Day

Cutera, NetEase, West Pharmaceutical, IDEXX Laboratories and Align Tech highlighted as Zacks Bull and Bear of the Day

Riya Anand headshot

Bet on These 3 MedTech Growth Stocks for 2021 & Beyond

Stocks like West Pharmaceutical Services (WST), IDEXX Laboratories (IDXX) and Align Technology (ALGN) make great picks for the long term.

Here's Why You Should Retain Inogen (INGN) Stock For Now

Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.

The Zacks Analyst Blog Highlights: Align Technology, West Pharmaceutical Services, Henry Schein and Merit Medical Systems

The Zacks Analyst Blog Highlights: Align Technology, West Pharmaceutical Services, Henry Schein and Merit Medical Systems

Trina Mukherjee headshot

3 Dental Stocks Poised to Perform Well in Second-Half 2021

Let's keep a watch on three lucrative stocks, WST, HSIC and MMSI, in the dental space that investors can add to their watchlist backed by robust long-term prospects.

Top Ranked Momentum Stocks to Buy for September 15th

CACC, UFPT, WST, and CASH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 15, 2021.

Here's Why You Should Invest in Intuitive Surgical (ISRG) Now

Intuitive Surgical (ISRG) continues to gain traction from improving adoption of da Vince Surgical System.

Here's Why You Should Retain PerkinElmer (PKI) Stock Now

PerkinElmer (PKI) continues to gain momentum from a solid product portfolio and healthy margins. However, forex woes linger.

Here is Why Growth Investors Should Buy West Pharmaceutical (WST) Now

West Pharmaceutical (WST) possesses solid growth attributes, which could help it handily outperform the market.

HealthEquity (HQY) Q2 Earnings & Revenues Beat Estimates

HealthEquity (HQY) witnesses solid growth in HSAs and records robust Interchange revenues in the second quarter of fiscal 2022.

The Zacks Analyst Blog Highlights: Regeneron, Vertex Pharmaceuticals and West Pharmaceutical Services

The Zacks Analyst Blog Highlights: Regeneron, Vertex Pharmaceuticals and West Pharmaceutical Services

John Blank headshot

A Short Trading Week: Global Week Ahead

The trading week is shorted to four days for stocks listed solely in the U.S. In turn, this Global Week Ahead looks to be dominated by non-U.S. events.

What Makes West Pharmaceutical Services (WST) a Strong Momentum Stock: Buy Now?

Does West Pharmaceutical Services (WST) have what it takes to be a top stock pick for momentum investors? Let's find out.

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

West Pharmaceutical (WST) Hits 52-Week High, Can the Run Continue?

West Pharmaceutical (WST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Cooper Companies (COO) Q3 Earnings & Revenues Beat Estimates

Cooper Companies' (COO) fiscal third-quarter earnings reflect solid segmental performance.

Patterson Companies (PDCO) Q1 Earnings & Revenues Top Estimates

Patterson Companies' (PDCO) fiscal first-quarter 2022 results benefit from strong segmental performance.